Alternative to Amlodipine for Hypertension with Cardiovascular Disease
For a patient with hypertension and cardiovascular disease without edema, switch to an ACE inhibitor (or ARB if ACE inhibitor is not tolerated) combined with a thiazide diuretic, as this combination provides superior cardiovascular protection and is the preferred regimen for patients with established coronary artery disease. 1
Primary Medication Recommendations
First-Line Combination Therapy
Patients with hypertension and chronic stable coronary artery disease should be treated with a regimen that includes:
- ACE inhibitor or ARB as the cornerstone of therapy, which provides proven cardiovascular protection and mortality reduction 1
- Thiazide or thiazide-type diuretic (such as chlorthalidone or hydrochlorothiazide), which has demonstrated superior outcomes in preventing heart failure compared to calcium channel blockers 1
- Beta-blocker if there is a history of prior myocardial infarction, as this is a Class I recommendation for at least 6 months post-MI 1
Specific Agent Selection
ACE Inhibitors/ARBs:
- ACE inhibitors are preferred as first-line therapy for patients with cardiovascular disease, with proven benefits in reducing cardiovascular events 1
- ARBs (such as candesartan or valsartan) are equivalent alternatives if ACE inhibitors cause intolerable cough or angioedema 1
- Both classes effectively lower blood pressure and provide cardiovascular protection 1
Thiazide Diuretics:
- Chlorthalidone demonstrated superiority over amlodipine in preventing heart failure in the ALLHAT trial, making it the preferred diuretic choice 1
- Thiazide diuretics are effective in elderly patients and those with isolated systolic hypertension 1
- Standard dosing for hypertension ranges from 12.5-25 mg daily for chlorthalidone or hydrochlorothiazide 1
Alternative Diuretic Option
Loop Diuretics (Torsemide):
- Torsemide 2.5-5 mg daily can be used as an alternative to thiazides for blood pressure control, with efficacy similar to thiazide diuretics 2, 3
- Torsemide has higher bioavailability (>80%) and longer half-life (3-4 hours) compared to furosemide, allowing once-daily dosing 2, 3
- This agent lowers diastolic blood pressure to below 90 mmHg in 70-80% of patients at low doses 2
- Torsemide is particularly useful if the patient has any degree of volume overload or renal impairment 3
Beta-Blocker Considerations
When to Add Beta-Blockers:
- Mandatory if history of myocardial infarction within the past 6 months (Class I recommendation) 1
- Strongly recommended for patients with chronic stable angina to reduce ischemic symptoms 1
- Carvedilol, metoprolol succinate, or bisoprolol are preferred agents if heart failure is present 1
- Beta-blockers should be avoided or used cautiously in patients with severe bradycardia, heart block, or decompensated heart failure 1
What NOT to Use
Avoid These Alternatives:
- Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) should be avoided if there is any left ventricular dysfunction or heart failure (Class III Harm recommendation) 1
- Clonidine should be avoided in patients with heart failure due to increased mortality risk observed with similar centrally-acting agents (Class III Harm recommendation) 1, 4
- Alpha-blockers (such as doxazosin) are not recommended as first-line therapy as they are less effective than other agents in preventing cardiovascular events 1
- Short-acting nifedipine must never be used due to risk of severe hemodynamic instability and increased adverse cardiovascular events 1, 5
Blood Pressure Targets
Target blood pressure for patients with cardiovascular disease:
- Primary target: <130/80 mmHg for patients with coronary artery disease 1, 6
- Minimum acceptable: <140/90 mmHg if the lower target cannot be tolerated 1
- Caution with diastolic pressure: Avoid lowering diastolic blood pressure below 60 mmHg in patients with evidence of myocardial ischemia, as this may worsen coronary perfusion 1, 6
Practical Implementation Algorithm
Step 1: Initiate ACE inhibitor (e.g., lisinopril 10-20 mg daily) or ARB (e.g., losartan 50-100 mg daily) 1
Step 2: Add thiazide diuretic (chlorthalidone 12.5-25 mg daily or hydrochlorothiazide 12.5-25 mg daily) if blood pressure remains >130/80 mmHg 1
Step 3: Add beta-blocker if history of MI or persistent angina (metoprolol succinate 25-100 mg daily or carvedilol 6.25-25 mg twice daily) 1
Step 4: If blood pressure still not controlled, consider adding a long-acting dihydropyridine calcium channel blocker (but NOT amlodipine due to the patient's situation) or increasing doses of existing medications 1
Common Pitfalls to Avoid
- Do not use monotherapy when blood pressure is >20/10 mmHg above goal; start with two agents from the outset 1
- Do not combine ACE inhibitor with ARB as this increases adverse events without additional cardiovascular benefit 1
- Do not use verapamil or diltiazem with beta-blockers in patients with any degree of left ventricular dysfunction, as this combination significantly increases risk 1
- Monitor potassium closely when combining ACE inhibitor/ARB with aldosterone antagonists or in patients with renal impairment 1
- Avoid rapid blood pressure reduction in patients with chronic hypertension and coronary disease, as this may precipitate myocardial ischemia 1